Cargando…
Novel inhibitors to ADP ribose phosphatase of SARS-CoV-2 identified by structure-based high throughput virtual screening and molecular dynamics simulations
The outbreak of a new coronavirus (SARS-CoV-2) was first identified in Wuhan, People's Republic of China, in 2019, which has led to a severe, life-threatening form of pneumonia (COVID-19). Research scientists all around the world have been trying to find small molecule drugs to treat COVID-19....
Autores principales: | Patel, Dhrumi C., Hausman, Katherine R., Arba, Muhammad, Tran, Annie, Lakernick, Phillip M., Wu, Chun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629772/ https://www.ncbi.nlm.nih.gov/pubmed/34891093 http://dx.doi.org/10.1016/j.compbiomed.2021.105084 |
Ejemplares similares
-
Discovering new potential inhibitors to SARS-CoV-2 RNA dependent RNA polymerase (RdRp) using high throughput virtual screening and molecular dynamics simulations
por: Brunt, Dylan, et al.
Publicado: (2022) -
Unraveling the binding mechanism of the active form of Remdesivir to RdRp of SARS-CoV-2 and designing new potential analogues: Insights from molecular dynamics simulations
por: Arba, Muhammad, et al.
Publicado: (2022) -
Computational Bioprospecting Guggulsterone against ADP Ribose Phosphatase of SARS-CoV-2
por: Kciuk, Mateusz, et al.
Publicado: (2022) -
Discovery of compounds that inhibit SARS-CoV-2 Mac1-ADP-ribose binding by high-throughput screening
por: Roy, Anu, et al.
Publicado: (2022) -
Proteome-wide identification of poly(ADP-ribose) binding proteins and poly(ADP-ribose)-associated protein complexes
por: Gagné, Jean-Philippe, et al.
Publicado: (2008)